冠心病防治新策略：从关注缺血到关注动脉粥样硬化
龚艳君,霍勇
摘要(Abstract)：
<正>缺血性心脏病是全球及我国死亡的首要病因~([1-2])。传统的缺血性心脏病的诊疗以“冠状动脉阻塞引起心肌缺血”为核心，主要针对缺血发作（如心绞痛、心肌梗死）干预，但此时疾病已进入晚期，干预效果有限。全球多位专家2025年4月在Lancet联合发文，提出动脉粥样硬化性冠状动脉疾病（atherosclerotic coronary artery disease,ACAD）的概念，强调疾病的本质是动脉粥样硬化斑块形成，而非缺血，倡导从传统“以缺血为中心”转向“以动脉粥样硬化斑块为中心”，强调早期预防、检测与干预，以应对全球疾病负担~([3])。
关键词(KeyWords)：
基金项目(Foundation):
作者(Author): 龚艳君,霍勇
参考文献(References)：
- [1] Yang L,Zheng B,Gong Y.Global,regional and national burden of ischemic heart disease and its attributable risk factors from 1990 to 2021:a systematic analysis of the Global Burden of Disease study 2021[J].BMC Cardiovasc Disord,2025,25(1):625.DOI:10.1186/s12872-025-05022-x.
- [2]刘明波,王增武.《中国心血管健康与疾病报告2024》概要(心血管疾病流行及介入诊疗状况)[J].中国介入心脏病学杂志,2025,33(12):687-695.DOI:10.3969/j.issn.1004-8812.2025.12.003.
- [3]Zaman S,Wasfy JH,Kapil V,et al.The Lancet Commission on rethinking coronary artery disease:moving from ischaemiato atheroma[J].Lancet,2025,405(10486):1264-1312.DOI:10.1016/S0140-6736(25)00055-8.
- [4] Nay or M,Brown K J,Vasan RS.The molecular basis of predicting atherosclerotic cardiovascular disease risk[J].Circ Res,2021,128(2):287-303.DOI:10.1161/CIRCRESAHA.120.315890.
- [5] Lloyd-Jones DM,Albert MA,Elkind M.The American Heart Association's focus on primordial prevention[J].Circulation,2021,144(15):e233-e235.DOI:10.1161/CIRCULATIONAHA.121.057125.
- [6]Crump C,Howell EA.Perinatal origins of cardiovascular health disparities across the life course[J].JAMA Pediatr,2020,174(2):113-114.DOI:10.1001/jamapediatrics.2019.4616.
- [7] Visseren FLJ,Mach F,Smulders YM,et al.2021ESC Guidelines on cardiovascular disease prevention in clinical practice[J].Eur Heart J,2021,42(34):3227-3337.DOI:10.1093/eurheartj/ehab484.
- [8] Patel J,Pallazola VA,Dudum R,et al.Assessment of coronary artery calcium scoring to guide statin therapy allocation according to risk-enhancing factors:the multi-ethnic study of atherosclerosis[J].JAMA Cardiol,2021,6(10):1161-1170.DOI:10.1001/j amacardio.2021.2321.
- [9]Spertus JA,Jones PG,Maron DJ,et al.Health-status outcomes with invasive or conservative care in coronary disease[J].N Engl J Med,2020,382(15):1408-1419.DOI:10.1056/NEJMoa1916370.